- Home
- SYK vs BMY Comparison
SYK vs BMY Comparison
Compare SYK & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYK
- BMY
- Stock Information
- Founded
- SYK 1941
- BMY 1887
- Country
- SYK United States
- BMY United States
- Employees
- SYK N/A
- BMY N/A
- Industry
- SYK Medical/Dental Instruments
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- SYK Health Care
- BMY Health Care
- Exchange
- SYK Nasdaq
- BMY Nasdaq
- Market Cap
- SYK 139.3B
- BMY 120.5B
- IPO Year
- SYK N/A
- BMY N/A
- Fundamental
- Price
- SYK $382.45
- BMY $46.88
- Analyst Decision
- SYK Buy
- BMY Hold
- Analyst Count
- SYK 19
- BMY 16
- Target Price
- SYK $424.28
- BMY $58.93
- AVG Volume (30 Days)
- SYK 1.6M
- BMY 16.6M
- Earning Date
- SYK 05-01-2025
- BMY 04-24-2025
- Dividend Yield
- SYK 0.88%
- BMY 5.29%
- EPS Growth
- SYK N/A
- BMY N/A
- EPS
- SYK 7.40
- BMY 2.67
- Revenue
- SYK $23,218,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- SYK $9.78
- BMY N/A
- Revenue Next Year
- SYK $7.53
- BMY N/A
- P/E Ratio
- SYK $51.69
- BMY $17.55
- Revenue Growth
- SYK 10.76
- BMY 4.62
- 52 Week Low
- SYK $314.93
- BMY $39.35
- 52 Week High
- SYK $406.19
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- SYK 61.98
- BMY 31.46
- Support Level
- SYK $363.08
- BMY $48.69
- Resistance Level
- SYK $383.99
- BMY $50.65
- Average True Range (ATR)
- SYK 8.72
- BMY 1.41
- MACD
- SYK 3.36
- BMY 0.11
- Stochastic Oscillator
- SYK 89.12
- BMY 8.60
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.